Ultrasound-Guided Nerve Block for Hip Fractures
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it does exclude those who have used certain blood thinners like NOACs within 48 hours or LMWH within specific time frames before the procedure.
What data supports the effectiveness of the treatment Ultrasound-Guided Nerve Block for Hip Fractures?
Research shows that ultrasound-guided femoral nerve blocks can effectively manage pain in patients with hip and femur fractures, providing an alternative to opioid medications like morphine. This method is also used successfully for pain relief after knee surgery, indicating its broader effectiveness in managing pain from various orthopedic conditions.12345
Is ultrasound-guided femoral nerve block generally safe for humans?
Research indicates that ultrasound-guided femoral nerve block is generally safe, with no recorded side effects in studies involving patients with femoral fractures. It has been effectively used for pain management in various conditions, including hip and femur fractures, without significant safety concerns.12346
How is the ultrasound-guided femoral nerve block treatment for hip fractures different from other treatments?
The ultrasound-guided femoral nerve block (FNB) is unique because it provides targeted pain relief by blocking specific nerves in the hip area, potentially reducing the need for systemic opioids like morphine, which can cause complications in elderly patients. This method also allows for the visualization of surrounding structures, which can help identify other issues, such as deep vein thrombosis, that might affect patient management.12357
What is the purpose of this trial?
The goal of the study is to evaluate whether pain control achieved by Ultrasound Guided Femoral Nerve Blockade (USFNB) is equal in efficacy to standard pain management practice of parenteral injection of opioid pain medication in patients presenting to the emergency department (ED) with hip fracture.
Research Team
Beatrice Hoffmann, MD PhD
Principal Investigator
Beth Israel Deaconess Medical
Eligibility Criteria
This trial is for adults over 18 who come to the emergency department with a confirmed hip fracture and have moderate to severe pain. They must be able to give consent and participate in the study.Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either Ultrasound Guided Femoral Nerve Blockade or standard parenteral opioid pain management
Follow-up
Participants are monitored for pain intensity reduction and side effects using Visual Analog Scale (VAS)
Treatment Details
Interventions
- Bupivacaine
- Morphine
- Ultrasound Guided Femoral Nerve Blockade
Bupivacaine is already approved in United States, European Union, Canada for the following indications:
- Local anesthesia for surgery
- Acute pain management
- Spinal anesthesia
- Local anesthesia for surgery
- Acute pain management
- Spinal anesthesia
- Local anesthesia for surgery
- Acute pain management
- Spinal anesthesia
Find a Clinic Near You
Who Is Running the Clinical Trial?
Beth Israel Deaconess Medical Center
Lead Sponsor